Taylor C, Meisel J, Foreman AJ, Russell C, et al. Using Oncotype DX breast recurrence score(R) assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer. Breast Cancer Res Treat 2023 Mar 10. doi: 10.1007/s10549-023-06890.
PMID: 36897465